Stock Taper
FOCL
EDAP TMS S.A. AMERICAN DEPOSITARY SHARES
NASDAQ
$4.15
▼ DOWN 3.04% (-0.13)

KEY STATISTICS

Market Cap$155.55 M
52w High$6.40
52w Low$1.75
Dividend Yield
Frequency
P/E-4.01
Volume104.83K
Shares Out.37.48M

COMPANY

LEADERSHIP

Ryan Rhodes
CHIEF EXECUTIVE
Ryan Rhodes

ABOUT

SECTOR
Healthcare
WENT PUBLIC
August 1, 1997
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
289

PRICE TARGET

Target High$15.00
Target Low$4.00
Target Median$10.00
Target Consensus$9.67

UPCOMING EARNINGS

DateNov 5, 2026
DayThursday
Rev. Est.$11.84M
NOV
5
THU

PRICE

$4.15 ▼ DOWN 3.04% (−$0.13)
$4.13$4.209:31 AM10:36 AM11:40 AM12:45 PM1:50 PM2:54 PM3:59 PM4.15

About EDAP TMS S.A. American Depositary Shares

http://www.focalone.com ↗

EDAP TMS SA develops and markets minimally invasive urological medical devices, including HIFU tumor ablation systems and urology devices for diagnosis and treatment, through its HIFU and UDS segments.

INDUSTRY

Medical - Devices

A PRODUCT EDAP TMS S.A. AMERICAN DEPOSITARY SHARES IS KNOWN FOR

Focal One i
Focal One i

Focal One is a FDA-cleared robotic HIFU system for precise, non-invasive prostate tissue ablation, featuring advanced imaging and planning, with potential for expansion into other clinical areas like endometriosis.

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity5
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score2

INSIDER TRADES

OFFICER: GENERAL COUNSEL & CORP SEC
Shah Sanket
Purchase · 5.0K shares
2026-08-14
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Rhodes Ryan
Purchase · 21.0K shares
2026-08-14
DIRECTOR
Schulz Fran
Purchase · 10.0K shares
2026-08-14
DIRECTOR
WILLSEY LANCE
Purchase · 50.0K shares
2026-08-14

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 1
1 GRADES IN THE LAST 12 MONTHS